Global Blood Therapeutics, Inc. Contracts & Agreements

66 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 1.875% Convertible Senior Notes Due 2028 between Global Blood Therapeutics, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Amendment No. 1 to License Agreement between Sanofi and Global Blood Therapeutics, Inc.
License Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Agreement and Plan of Merger among Pfizer Inc., Ribeye Acquisition Corp., and Global Blood Therapeutics, Inc. dated August 7, 2022
Merger Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2022
Global Blood Therapeutics, Inc. Amended and Restated U.S. Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Global Blood Therapeutics, Inc. Amended and Restated Severance and Change in Control Policy
Severance Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Global Blood Therapeutics, Inc. Non-Employee Director Compensation Policy (Effective January 1, 2022)
Compensation Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Indenture Agreement for 1.875% Convertible Senior Notes due 2028 between Global Blood Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Capped Call Transaction Confirmation between Global Blood Therapeutics, Inc. and [Dealer]
Financing Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Employment Offer Letter for EVP, Chief Human Resources Officer between Global Blood Therapeutics, Inc. and Carrie Krehlik
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2021
Employment Agreement between Global Blood Therapeutics, Inc. and Kim M. Smith-Whitley, MD (EVP, Head of Research & Development)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2021
License Agreement between Sanofi and Global Blood Therapeutics, Inc. dated March 12, 2021
License Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Global Blood Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Global Blood Therapeutics, Inc. Amended and Restated Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2021
Global Blood Therapeutics, Inc. Amended and Restated 2017 Inducement Equity Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2021
Global Blood Therapeutics, Inc. Amended and Restated Severance and Change in Control Policy (2020)
Severance Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2021
Global Blood Therapeutics, Inc. Non-Employee Director Compensation Policy (Effective January 1, 2021)
Compensation Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2021
Global Blood Therapeutics, Inc. Amended and Restated 2017 Inducement Equity Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2020
Global Blood Therapeutics, Inc. Amended and Restated Severance and Change in Control Policy (2020)
Severance Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2020
Global Blood Therapeutics, Inc. Amended and Restated 2015 Employee Stock Purchase Plan
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2020
Global Blood Therapeutics, Inc. Non-Employee Director Compensation Policy (as of March 24, 2020)
Compensation Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2020
Description of Global Blood Therapeutics, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2020
License and Collaboration Agreement between Syros Pharmaceuticals, Inc. and Global Blood Therapeutics, Inc. (December 17, 2019)
License Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2020
Loan Agreement between Global Blood Therapeutics, Inc. and BioPharma Credit PLC & BioPharma Credit Investments V (Master) LP (December 17, 2019)
Loan Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2020
Global Blood Therapeutics, Inc. Amended and Restated Severance and Change in Control Policy (2020)
Severance Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2020
Global Blood Therapeutics, Inc. Cash Incentive Bonus Plan (as Amended and Restated January 7, 2020)
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2020
Global Blood Therapeutics, Inc. Change in Control Policy (as Amended)
Change of Control Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2019
Employment Offer Letter between Global Blood Therapeutics, Inc. and Eric Fink (Chief Human Resources Officer)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2019
Underwriting Agreement between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co. (June 26, 2019)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2019
Global Blood Therapeutics, Inc. Employment Offer Letter to Jung Choi (Chief Business and Strategy Officer)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2019
Global Blood Therapeutics, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2019
Global Blood Therapeutics, Inc. Chief Scientific Officer Employment Agreement with Brian E. Cathers, PhD (January 17, 2019)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2019
Underwriting Agreement between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co. (December 7, 2018)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2018
Global Blood Therapeutics, Inc. Change in Control Policy (as Amended)
Change of Control Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Global Blood Therapeutics, Inc. Employment Offer Letter to Peter Radovich (VP of Program Leadership and Business Strategy)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Global Blood Therapeutics, Inc. Employment Agreement with Jung Choi (Chief Business and Strategy Officer)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Employment Offer Letter between Global Blood Therapeutics, Inc. and David L. Johnson (Chief Commercial Officer)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Underwriting Agreement between Global Blood Therapeutics, Inc. and Wells Fargo Securities, LLC (March 8, 2018)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2018
Underwriting Agreement between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co. (December 15, 2017)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2017
Global Blood Therapeutics, Inc. Change in Control Policy (as Amended)
Change of Control Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2017
Separation and Release Agreement between Global Blood Therapeutics, Inc. and Eleanor L. Ramos, M.D.
Separation Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2017
Global Blood Therapeutics, Inc. Employment Agreement with Patricia Suvari, JD (Chief Legal Officer)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2017
Underwriting Agreement between Global Blood Therapeutics, Inc. and Cantor Fitzgerald & Co. (February 21, 2017)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2017
Underwriting Agreement between Global Blood Therapeutics, Inc. and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and Other Underwriters
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2016
Employment Offer Letter between Global Blood Therapeutics, Inc. and Jeffrey Farrow (2016)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2016
First Amendment to Amended and Restated Investors’ Rights Agreement by Global Blood Therapeutics, Inc. and Investors
Investor Rights Agreements
Global Blood Therapeutics, Inc.
Biotechnology
CA
2016
Employment Offer Letter between Global Blood Therapeutics, Inc. and Hing Leung Sham, Ph.D.
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2016
Separation and Consulting Agreement between Global Blood Therapeutics, Inc. and Uma Sinha, Ph.D.
Separation Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2016
Global Blood Therapeutics, Inc. Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2016
Underwriting Agreement between Global Blood Therapeutics, Inc. and Morgan Stanley & Co. LLC, Goldman, Sachs & Co. (2015)
Underwriting Agreements
Global Blood Therapeutics, Inc.
Biotechnology
NY
2015
Global Blood Therapeutics, Inc. Common Stock Certificate Specimen
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
Global Blood Therapeutics, Inc. 2015 Stock Option and Incentive Plan
Bonus & Incentive Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
Director Indemnification Agreement between Global Blood Therapeutics, Inc. and Director
Indemnification Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
Global Blood Therapeutics, Inc. 2015 Employee Stock Purchase Plan
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
Amended and Restated Investors' Rights Agreement between Global Blood Therapeutics, Inc. and Investors (December 22, 2014)
Investor Rights Agreements
Global Blood Therapeutics, Inc.
Biotechnology
CA
2015
Global Blood Therapeutics, Inc. 2012 Stock Option and Grant Plan
Stock Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
Global Blood Therapeutics, Inc. Employment Agreement with Ted W. Love, M.D. (Chief Executive Officer)
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
Employment Agreement between Global Blood Therapeutics, Inc. and Eleanor L. Ramos, M.D.
Employment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
Assignment and Assumption of Lease Agreement between Myokardia, Inc. and Global Blood Therapeutics, Inc. for 400 East Jamie Court
Assignment Agreements
Global Blood Therapeutics, Inc.
Biotechnology
DE
2015
Director Appointment and Compensation Agreement between Global Blood Therapeutics, Inc. and Willie L. Brown, Jr.
Compensation Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
Director Appointment and Compensation Agreement between Global Blood Therapeutics, Inc. and Mark L. Perry
Compensation Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
First Amendment to Lease Agreement between HCP Oyster Point III LLC and Global Blood Therapeutics, Inc.
Lease Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2018
Lease Agreement between HCP Oyster Point III LLC and Global Blood Therapeutics, Inc. for The Cove at Oyster Point
Lease Agreements
Global Blood Therapeutics, Inc.
Biotechnology
CA
2017
Sublease Agreement between NexSteppe Inc. and Global Blood Therapeutics, Inc. dated September 15, 2016
Lease Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2016
Lease Agreement between ARE-EAST JAMIE COURT, LLC and Global Blood Therapeutics, Inc. for 400 East Jamie Court, South San Francisco
Lease Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
Lease Agreement between ARE-EAST JAMIE COURT, LLC and MyoKardia, Inc. for 400 East Jamie Court, South San Francisco
Lease Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2015
Director Appointment and Compensation Agreement between Global Blood Therapeutics, Inc. and Deval Patrick
Global Blood Therapeutics, Inc.
Biotechnology
2015